The AWARD trials demonstrated preservation of kidney function in patients with type 2 diabetes, adding another dimension to its value beyond pure weight loss
GLP-1 Clarification: OzemPatches is not a GLP-1 medication
at 45 d.p.i.), did not result in increased efficacy (38% decrease in worm and 18% reduction in egg burdens, respectively)
GLP-1 RAs increase insulin secretion in response to a rise in blood sugar after a meal, lowers glucagon secretion, and slows down stomach emptying
Brophy, for her part, is weighing multiple variables
For those wondering about the process, semaglutide is typically administered as a weekly injection under the skin